background
antibodi
constitut
power
tool
studi
protein
function
protein
local
proteinprotein
interact
well
diagnost
therapeut
purpos
highthroughput
antibodi
develop
requir
faster
methodolog
lower
antigen
consumpt
result
describ
novel
methodolog
select
human
monoclon
recombin
antibodi
combin
vitro
protein
express
phage
display
antibodi
librari
antibodi
microarray
applic
combin
methodolog
permit
us
gener
human
singlechain
variabl
fragment
scfv
two
protein
green
fluoresc
protein
gfp
thioredoxin
trx
short
time
use
low
purifi
protein
scfv
show
specif
reactiv
respect
target
work
well
elisa
western
blot
scfv
abl
recognis
low
ng
protein
respect
target
western
blot
conclus
work
describ
novel
miniatur
methodolog
obtain
human
monoclon
recombin
antibodi
target
shorter
time
methodolog
use
protein
protocol
could
easili
adapt
highthroughput
procedur
antibodi
product
crucial
challeng
proteom
era
use
genom
inform
better
understand
protein
express
protein
cellular
distribut
function
discoveri
normal
also
patholog
process
antibodi
develop
everi
human
protein
prerequisit
improv
knowledg
sever
highthroughput
altern
develop
gener
antibodi
entir
proteom
human
protein
atla
initi
http
wwwproteinatlasorg
sanger
institut
antibodi
atla
databas
nci
clinic
proteom
hupo
human
antibodi
initi
http
www
hupoorgresearchhai
sever
eufund
consortia
proteomebind
affinityproteom
affinom
http
wwwproteomebindersorg
good
exampl
altern
product
mab
andor
rabbit
antibodi
requir
larg
amount
antigen
timeconsum
due
immun
step
anim
case
mab
screen
clone
select
take
month
year
develop
recombin
antibodi
singlechain
fv
scfv
format
good
altern
obtain
highaffin
antibodi
target
without
timeconsum
immun
affin
scfv
target
might
compar
mab
pab
case
even
higher
gener
rule
scfv
possess
sever
advantag
comparison
igg
fab
higher
tissu
penetr
rapid
clarif
moreov
antibodi
phage
display
human
librari
becom
particularli
use
product
develop
antibodi
immunotherapi
differ
diseas
vitro
phage
display
pipelin
setup
gener
antibodi
complet
human
proteom
select
still
carri
manual
screen
phage
display
antibodi
librari
constrain
necess
consider
amount
antigen
least
mg
protein
whole
procedur
select
screen
valid
necess
signific
amount
purifi
target
protein
product
select
also
screen
antibodi
one
main
problem
develop
antibodi
constitut
major
bottleneck
associ
three
altern
describ
despit
progress
autom
protein
express
limit
step
get
toxic
difficulttoexpress
membran
protein
rapid
effici
costeffect
protein
express
purif
strategi
requir
product
antibodi
target
tri
minim
time
amount
requir
protein
cellfre
express
power
flexibl
technolog
new
advanc
technolog
face
higher
demand
highthroughput
protein
synthesi
advanc
includ
use
cellextract
differ
background
prokaryot
eukaryot
modul
reduc
environ
correct
product
disulfid
bond
incorpor
deterg
lipid
bilay
nonlipoprotein
particl
express
membran
protein
final
autom
procedur
furthermor
cellfre
system
offer
sever
advantag
tradit
cellbas
express
method
includ
lower
sensit
product
toxic
suitabl
highthroughput
strategi
reduc
reaction
volum
process
time
recent
improv
translat
effici
result
yield
compar
cellbas
express
system
difficulttoexpress
protein
bacteri
wheat
germ
reticulocyt
lysat
use
vitro
express
system
wide
varieti
strategi
rapid
translat
system
rt
bacterialbas
commerci
avail
cellfre
protein
express
system
use
highthroughput
express
inner
outer
membran
protein
anaplasma
marginal
riken
structur
genom
initi
japan
report
bacteri
base
cellfre
protein
express
product
randomli
chosen
mous
cdna
clone
yield
higher
mgml
sinc
sever
develop
significantli
improv
yield
vitro
express
protein
rang
milligram
protein
per
ml
reaction
mix
anoth
interest
initi
human
protein
factori
express
human
protein
use
wheatgerm
vitro
protein
express
system
gateway
technolog
author
report
success
rate
protein
express
human
protein
among
detect
solubl
protein
clone
success
highthroughput
initi
base
vitro
protein
express
yield
mgml
appli
protein
array
nuclear
magnet
reson
crystal
studi
regard
use
low
amount
protein
microarray
format
particularli
use
low
consumpt
autom
antibodi
array
initi
design
captur
detect
simultan
multipl
analyt
high
affin
select
human
biolog
sampl
plasma
serum
tissu
order
studi
variat
biolog
status
explor
use
proteom
techniqu
test
scfv
antibodi
librari
differ
antigen
time
order
identifi
specif
scfv
increas
throughput
screen
step
minim
requir
protein
report
propos
novel
methodolog
develop
scfv
antibodi
use
human
phage
display
antibodi
librari
short
time
four
week
protein
furthermor
method
could
autom
highthroughput
format
obtain
antibodi
demand
target
take
advantag
cellfre
protein
express
antibodi
phage
display
scfv
antibodi
microarray
cdnasencod
gfp
trx
clone
pivex
plasmid
respect
use
vitro
transcriptiontransl
reaction
cellfre
express
yield
purifi
protein
per
rt
reaction
puriti
homogen
express
protein
confirm
sdspage
western
blot
use
rt
reaction
figur
b
protein
immobil
magnet
bead
use
get
antibodi
phage
display
extens
wash
pb
talon
dynabead
divid
five
tube
contain
bead
one
four
round
select
librari
fifth
one
alexa
fluor
label
remark
phage
enrich
protein
observ
elisa
round
biopan
figur
total
scfv
specif
antigen
select
recov
rd
th
round
select
purifi
periplasm
fraction
e
coli
cell
directli
print
duplic
onto
fast
nitrocellulos
slide
figur
although
scfv
express
differ
observ
among
differ
clone
correct
print
pattern
detect
indic
adequ
print
condit
figur
amount
scfv
print
array
determin
print
serial
dilut
previous
report
antigastrin
scfv
construct
regress
line
use
median
fluoresc
signal
scfv
regress
line
get
amount
scfv
print
array
approxim
pg
antibodi
print
spot
array
qualiti
scfv
antibodi
microarray
confirm
absenc
cross
contamin
success
spot
posit
control
well
buffer
spot
show
correct
reactiv
intraassay
reproduc
assess
compar
result
two
replica
print
within
chip
clone
gave
r
figur
evalu
specif
scfv
gfp
trx
perform
use
scfv
antibodi
microarray
cellfre
express
purifi
gfp
trx
protein
directli
label
fluor
probe
antibodi
microarray
figur
microarray
recombin
scfv
simultan
test
scfv
obtain
antigen
also
use
control
select
highlyspecif
scfv
show
crossreact
antigen
figur
c
figur
cellfre
protein
express
character
cell
free
gfp
trx
express
purif
dynabead
assess
sdspage
coomassi
blue
stain
u
unpurifi
total
protein
extract
p
protein
purifi
dynabead
b
western
blot
analysi
protein
use
peroxidaselabel
antihi
u
unpurifi
total
protein
extract
p
protein
purifi
dynabead
c
elisa
character
polyclon
phage
differ
round
biopan
peroxidaselabel
follow
tmb
incub
develop
signal
histag
bsa
gst
use
neg
control
print
condit
scfv
antibodi
microarray
reproduc
print
map
microarray
compris
scfv
gfp
trx
control
use
assay
red
box
mab
dilut
yellow
box
mab
dilut
blue
box
crude
trx
top
gfp
bottom
rt
extract
dilut
grey
box
print
buffer
green
box
scfv
right
left
dilut
b
repres
imag
microarray
probe
anticmyc
antibodi
assess
correct
print
scfv
detect
cmyc
antibodi
slide
incub
alexa
fluor
goat
antimous
igg
antibodi
white
spot
indic
satur
green
signal
intens
c
scfv
spot
duplic
onto
fast
nitrocellulos
coat
slide
verifi
intraassay
reproduc
replic
spot
show
uniform
intens
either
visual
genepix
analysi
two
intens
valu
clone
quantifi
plot
assess
intraarray
reproduc
figur
screen
specif
scfv
use
microarray
format
cell
freeexpress
protein
label
alexafluor
incub
gfpand
trxspecif
scfv
microarray
identifi
highli
specif
scfv
binder
e
coliexpress
protein
use
control
select
gfpspecif
scfv
left
perform
microarray
cell
freeexpress
gfp
trx
control
right
perform
microarray
e
coli
express
protein
follow
polyclon
antigfp
monoclon
antiflag
alexafluor
label
antibodi
gave
green
fluoresc
signal
white
box
scfv
antibodi
gfp
show
least
higher
fluoresc
signal
control
trx
valu
red
box
scfv
show
nonspecif
bind
gfp
b
antigfp
scfv
clone
test
elisa
use
gfp
gst
compar
microarray
technolog
elisa
screen
c
select
trxspecif
scfv
left
perform
microarray
cell
freeexpress
trx
gfp
control
right
perform
microarray
e
coliexpress
protein
follow
polyclon
antigfp
antibodi
monoclon
antiflag
alexafluor
label
antibodi
white
box
reactiv
scfv
antibodi
detect
antibodi
microarray
trx
show
least
higher
fluoresc
signal
control
gfp
valu
red
box
scfv
show
nonspecif
bind
trx
antitrx
scfv
clone
test
elisa
use
trx
tag
bsa
compar
perform
microarray
technolog
identifi
trx
scfv
binder
elisa
screen
green
arrow
indic
top
three
scfv
gave
highest
microarray
signal
gfp
trx
valid
immunolog
techniqu
test
reproduc
select
system
use
also
gfp
trx
protein
express
e
coli
follow
fluoresc
label
antibodi
figur
c
although
signal
intens
usual
stronger
background
fluoresc
lower
e
colideriv
protein
similar
reactiv
pattern
observ
cellfre
purifi
protein
red
e
coliexpress
gfp
trx
green
indic
adequ
perform
express
system
microarray
screen
check
effect
potenti
scfv
denatur
print
demonstr
util
screen
antibodi
microarray
test
scfv
binder
antigen
elisa
compar
number
scfv
binder
found
elisa
antibodi
microarray
antibodi
microarray
found
gfpspecif
scfv
higher
signal
neg
control
microarray
incub
trx
elisa
found
scfv
least
higher
signal
neg
control
figur
obtain
coincid
gfpspecif
scfv
elisa
antibodi
microarray
regard
trx
scfv
binder
found
elisa
scfv
higher
signal
neg
control
figur
antibodi
microarray
figur
also
found
trxspecif
scfv
higher
signal
neg
control
microarray
incub
gfp
inde
abl
detect
trx
scfv
binder
techniqu
coincid
techniqu
collect
data
support
use
antibodi
microarray
screen
identifi
highlyspecif
scfv
antibodi
altern
convent
elisa
confirm
valu
scfv
obtain
antibodi
microarray
screen
character
three
scfv
show
strongest
reactiv
vitroexpress
antigen
scfv
test
elisa
compar
reactiv
vitroexpress
protein
e
coliexpress
protein
result
similar
three
antigfp
scfv
figur
b
two
scfv
show
strong
recognit
antibodi
microarray
also
best
elisa
howev
although
work
well
assay
figur
b
scfv
show
lower
correl
antibodi
microarray
elisa
valu
scfv
select
three
per
antigen
recognis
target
protein
western
blot
analysi
without
crossreact
figur
inde
scfv
abl
detect
low
ng
protein
westernblot
indic
suitabl
scfv
techniqu
inde
show
time
lower
sensit
trx
mab
flag
epitop
figur
final
six
scfv
sequenc
scfvsencod
dna
sequenc
differ
data
shown
scfv
display
signific
variabl
cdr
also
framework
consequ
origin
mehta
librari
antibodi
use
studi
protein
express
local
within
tissu
cell
organel
proteinprotein
interact
protein
function
moreov
antibodi
multipl
clinic
use
diagnosi
treatment
diseas
studi
character
human
proteom
necessari
establish
highthroughput
methodolog
test
multipl
antibodi
differ
protein
propos
new
methodolog
rais
antibodi
potenti
protein
target
antibodi
demand
fast
method
obtain
recombin
human
monoclon
antibodi
antigen
protein
necessari
perform
whole
procedur
sinc
took
advantag
methodolog
requir
minim
amount
protein
vitro
protein
express
purif
ii
antibodi
phage
display
iii
scfv
antibodi
microarray
screen
approach
avoid
product
consider
amount
protein
necessari
immun
screen
step
usual
bottleneck
antibodi
develop
hand
dedic
person
could
produc
antibodi
week
calcul
work
day
per
week
day
amplif
dna
purif
vitro
protein
express
purif
dynabead
ii
day
threefour
round
biopan
phage
display
e
coli
amplif
iii
day
print
screen
scfv
antibodi
microarray
iv
day
product
verif
scfv
result
figur
methodolog
could
adapt
highthroughput
system
inde
techniqu
use
report
previous
adapt
highthroughput
assay
one
main
advantag
approach
reli
util
vitro
bacteri
cellfre
express
differ
report
support
express
strategi
yield
low
protein
enough
get
antibodi
protein
recoveri
yield
amount
could
scale
vitro
much
necessari
obtain
protein
requir
approach
initi
cellfre
express
restrict
sever
limit
especi
express
transmembran
protein
protein
rich
disulfid
bond
howev
advanc
vitro
technolog
minim
limit
includ
sever
compon
like
canin
pancreat
microsom
membran
differ
dtt
ratio
protein
disulfid
isomeras
correct
fold
product
protein
present
disulfid
bond
differ
deterg
lipid
bilay
express
membran
protein
microarray
format
antibodi
screen
show
differ
advantag
consum
minim
amount
protein
ii
sensit
iii
improv
specif
iv
suitabl
highthroughput
screen
antibodi
time
identifi
recombin
antibodi
particular
protein
globalbind
profil
simultan
gener
differ
antibodi
produc
differ
protein
print
array
permit
select
highli
specif
non
crossreact
antibodi
microarray
set
could
print
spot
highdens
antibodi
format
per
slide
sinc
scfv
test
duplic
per
antigen
could
significantli
increas
multiplex
methodolog
test
antibodi
target
simultan
slide
moreov
use
recombin
antibodi
microarray
format
alter
significantli
scfv
bind
properti
print
describ
fraction
antibodi
work
well
print
surfac
microarray
due
loss
activ
denatur
degrad
print
array
storag
explor
fact
could
lose
total
scfv
due
denatur
antibodi
microarray
decid
test
scfv
elisa
compar
perform
microarray
verifi
use
antibodi
microarray
identif
scfv
binder
interestingli
abl
identifi
similar
number
scfv
binder
screen
coincid
gfp
trx
respect
data
support
util
antibodi
microarray
screen
step
consum
alexafluor
protein
remark
scfv
prepar
use
scfv
phage
display
librari
display
multipl
scaffold
framework
avoid
use
scfv
antibodi
librari
figur
applic
scfv
elisa
wb
select
scfv
test
elisa
cell
freeexpress
protein
e
colideriv
gfp
scfvtrx
protein
use
bsa
gst
neg
control
b
intens
fluoresc
signal
gfp
trxspecif
scfv
comparison
scfv
control
signal
buffer
obtain
normal
data
microarray
incub
fluor
labelledgfp
fluor
labelledtrx
anti
cmyc
follow
alexafluor
antimous
igg
respect
c
differ
amount
gfp
scfvtrx
separ
sdspage
transfer
nitrocellulos
membran
determin
sensit
antigfp
antitrx
scfv
dilut
primari
antibodi
follow
anticmyc
tag
peroxidaselabel
antimous
igg
antibodi
respect
mab
flag
mab
use
posit
control
detect
target
protein
specif
design
antibodi
microarray
usual
possess
one
fix
scaffold
develop
new
fast
method
produc
scfv
antibodi
use
cellfre
express
protein
naiv
scfv
antibodi
librari
combin
antibodi
microarray
format
screen
scfv
use
differ
applic
elisa
antibodi
microarray
western
blot
antibodi
product
technolog
could
especi
applic
difficulttoexpress
toxic
protein
amount
avail
protein
might
limit
step
plasmid
pivexgfp
use
cell
free
transcriptiontransl
system
produc
trx
gfp
respect
plasmid
dna
ethanol
precipit
use
templat
vitro
transcript
translat
use
rapid
translat
system
rt
kit
roch
appli
system
rt
reaction
contain
dna
templat
solut
ecoli
lysat
reaction
mix
amino
acid
methionin
reconstitut
buffer
dna
rnasefre
water
incub
h
rpm
thermomix
eppendorf
rt
reaction
gfp
trx
exclus
use
analyz
qualiti
express
purifi
protein
dynabead
coomassi
blue
stain
sdspage
gel
altern
immunoblot
use
antibodi
roch
one
rt
reaction
use
determin
enrich
biopan
procedur
verifi
scfv
bind
elisa
bsa
sigma
e
coliexpress
ge
irrelev
scfv
fuse
trx
use
control
protein
studi
scfvtrx
protein
produc
e
coli
accord
establish
procedur
briefli
novagen
contain
gstcdna
contain
cdna
encod
scfvtrx
use
transform
e
coli
cell
protein
express
purifi
affin
chromatographi
hitrap
chelat
column
ge
healthcar
select
proteinspecif
scfv
phagemid
librari
human
scfv
mehta
librari
kind
gift
wayn
marasco
danafarb
cancer
center
usa
use
scfv
product
mehta
scfv
contain
cmyc
tag
detect
purif
phage
display
select
perform
use
protein
attach
talon
dynabead
briefli
cellfre
express
protein
attach
dynabead
tag
incub
rt
reaction
magnet
bead
five
equal
aliquot
prepar
four
round
select
one
direct
label
protein
exhaust
wash
pb
magnet
bead
block
bsa
pb
pbsbsa
h
room
temperatur
wash
mehta
ii
librari
dilut
pbsbsa
preincub
magnet
bead
remov
nonspecif
binder
ad
solut
incub
h
room
temperatur
perform
four
round
biopan
get
specif
scfv
gfp
trx
round
select
includ
neg
subtract
phage
empti
dynabead
bead
wash
time
tween
min
room
temperatur
rpm
lab
roller
prior
elut
final
wash
step
pb
perform
remov
deterg
media
phage
elut
glycin
ph
min
room
temperatur
lab
roller
rpm
final
phage
neutral
tri
ph
amplif
phage
four
round
biopan
perform
essenti
describ
barba
et
al
minor
modif
briefli
elut
phage
first
round
select
second
success
round
select
use
infect
ml
exponenti
phase
blue
e
coli
cell
min
room
temperatur
ml
sb
medium
g
mop
g
trypton
g
yeast
extract
l
water
ph
contain
mgml
carbenicillin
sigma
mgml
tetracyclin
ad
cell
cultur
incub
h
rpm
mgml
carbenicillin
sigma
ad
cell
cultur
addit
h
rpm
ml
helper
phage
pfu
ad
cell
cultur
togeth
ml
prewarm
sb
medium
contain
mgml
carbenicillin
mgml
tetracyclin
media
incub
rpm
h
final
mgml
kanamycin
ad
medium
solut
incub
overnight
day
cultur
centrifug
rpm
min
supernat
contain
phage
suspens
mix
g
sigma
g
nacl
merck
complet
dissolut
kept
ice
min
phage
centrifug
g
min
phage
resuspend
ml
bsa
sigma
pb
ml
phage
solut
directli
use
subsequ
round
biopan
describ
nineti
six
coloni
randomli
pick
rd
th
round
biopan
gfp
trx
individu
coloni
ad
plate
contain
ampicillin
glucos
grown
overnight
next
day
cultur
dilut
plate
contain
ampicillin
glucos
iptg
ad
mm
final
concentr
cultur
incub
overnight
scfv
purif
cell
spun
resuspend
te
mm
trishcl
ph
mm
edta
mm
nacl
sucros
kept
ice
min
periplasm
fraction
obtain
centrifug
rpm
min
scfvcontain
periplasm
dilut
pb
tween
pbst
directli
array
duplic
onto
fast
slide
whatman
mous
monoclon
antibodi
mgml
novagen
fold
dilut
start
mgml
scfv
contain
cmyc
tag
cterminu
use
posit
control
pbst
neg
control
fast
nitrocellulos
slide
schleicher
schuell
whatman
print
humid
use
microarray
omnigrid
genemachin
microspot
diamet
stealth
pin
reservoir
telechem
pin
fix
dip
prespot
time
print
approxim
nl
solut
per
spot
separ
dot
slide
kept
overnight
insid
array
humid
immobil
antibodi
nitrocellulos
slide
store
use
cellfre
express
gfp
trx
label
fluor
microscal
protein
label
kit
invitrogen
protein
attach
dynabead
elut
mm
phosphat
buffer
nacl
mm
imidazol
ph
extens
dialys
pb
purifi
protein
lyophilis
concentr
label
microarray
slide
block
skim
milk
pb
mpb
h
room
temperatur
either
cell
free
alexafluor
gfp
trx
e
coliexpress
gfp
trx
anticmyc
antibodi
roch
mpb
ad
h
room
temperatur
incub
secures
hybrid
chamber
grace
biolab
microarray
wash
three
time
pbst
min
detect
alexafluor
trx
microarray
air
dri
directli
scan
describ
detect
bound
gfp
trx
protein
control
slide
incub
rabbit
polyclon
antigfp
ml
abcam
monoclon
antiflag
sigma
h
wash
incub
alexa
fluor
goat
antirabbit
igg
invitrogen
alexa
fluor
goat
antimous
igg
invitrogen
respect
h
dark
detect
cmyc
antibodi
slide
incub
alexa
fluor
goat
antimous
igg
antibodi
ml
three
min
wash
pbst
microarray
air
dri
scan
packard
biochip
technolog
use
nm
nm
laser
alexa
alexa
respect
genepix
pro
imag
analysi
softwar
use
quantif
analysi
result
phagemid
dna
individu
scfv
posit
coloni
amplifi
pcr
primer
pelbforward
cmycrevers
briefli
cdna
encod
scfv
amplifi
use
initi
denatur
step
min
follow
cycl
min
min
min
final
step
min
exonucleas
usb
shrimp
alkalin
phosphatas
usb
ad
pcr
product
remov
contamin
sequenc
carri
dna
sequenc
appli
biosystem
elisa
flexibl
microtit
plate
falcon
bd
bioscienc
coat
overnight
cellfre
purifi
gfp
trx
bsa
gst
use
neg
control
wash
three
time
pb
plate
block
mpb
h
room
temperatur
either
differ
dilut
phage
suspens
periplasm
fraction
test
presenc
mpb
h
wash
peroxidaselabel
dilut
mpb
anticmyc
roch
detect
phage
scfv
respect
ad
h
wash
peroxidas
reaction
develop
tmb
substrat
sigma
reaction
stop
h
absorpt
measur
nm
western
blot
analysi
protein
transfer
nitrocellulos
membran
gfp
trx
detect
use
peroxidaseconjug
roch
altern
scfvtrx
control
protein
detect
correspond
scfv
ngml
concentr
signal
develop
use
anticmyc
tag
roch
follow
peroxidaseconjug
antimous
igg
sigma
incub
h
ecl
reagent
use
final
detect
moreov
gener
fact
sheet
report
minimum
inform
protein
affin
reagent
miapar
includ
procedur
data
report
scfv
produc
studi
gfp
addit
file
trx
addit
file
addit
file
miaparcompli
document
human
antigfp
scfv
file
includ
miaparcompli
document
present
inform
product
human
antigfp
scfv
describ
manuscript
addit
file
miaparcompli
document
human
antitrx
scfv
file
includ
miaparcompli
document
present
inform
product
human
antitrx
scfv
describ
manuscript
list
abbrevi
scfv
singlechain
variabl
fragment
gfp
green
fluoresc
protein
mab
monoclon
antibodi
matrix
pab
polyclon
antibodi
trx
thioredoxin
